Редактирование: Aging genes 5-9 (раздел)

==PCSK9==

* {{medline-title
|title=Lipoprotein removal mechanisms and aging: implications for the cardiovascular health of the elderly.
|date=04.2020
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32011347
|full-text-url=https://sci-hub.do/10.1097/MED.0000000000000529
}}
* {{medline-title
|title=The role of proprotein convertase subtilisin-kexin type 9 ([[PCSK9]]) in the vascular aging process - is there a link?
|date=10.2019
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31708986
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836637
}}
* {{medline-title
|title=[[PCSK9]] Inhibitors Show Value for Patients and the US Health Care System.
|date=12.2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29241886
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929151
}}
* {{medline-title
|title=Association between lipoprotein (a) and proprotein convertase substilisin/kexin type 9 in patients with heterozygous familial hypercholesterolemia: A case-control study.
|date=02.2018
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29129821
|full-text-url=https://sci-hub.do/10.1016/j.metabol.2017.11.004
}}
* {{medline-title
|title=What's next for dyslipidemia management? The 2013 ACC/AHA Guidelines, the NLA recommendations, and beyond.
|date=05-06.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27156942
|full-text-url=https://sci-hub.do/10.1016/j.japh.2015.12.017
}}
* {{medline-title
|title=Impact of age and sex on the development of atherosclerosis and expression of the related genes in apoE deficient mice.
|date=15.01.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26592663
|full-text-url=https://sci-hub.do/10.1016/j.bbrc.2015.11.064
}}
* {{medline-title
|title=[[[[PC]]SK9]]: a key modulator of cardiovascular health.
|date=14.03.2014
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24625727
|full-text-url=https://sci-hub.do/10.1161/CIRCRESAHA.114.301621
}}